Anlotinib-Induced Broncho-Pericardial/Pleural Fistula in Patients Suffering from Lung Cancer (First Report)

被引：0
|
作者：
Deng, P. [1 ]
Hu, C. [1 ]
Li, Y. [1 ]
Yang, H. [1 ]
Chen, X. [2 ]
Tan, J. [1 ]
机构：
[1] Cent S Univ, Resp Med Dept, Xiangya Hosp, Changsha, Hunan, Peoples R China
[2] Cent S Univ, Xiangya Hosp, Cardiol Dept, Changsha, Hunan, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Anlotinib; Broncho-pericardial/pleural fistula; Lung cancer;
D O I：
10.1016/j.jtho.2019.08.2322
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP1.14-37
引用
收藏
页码：S1046 / S1046
页数：1
相关论文
共 20 条
  • [1] PYOPNEUMOPERICARDIUM: A CASE OF A BRONCHO-PERICARDIAL FISTULA FROM A CAVITARY LUNG MASS
    Schrank, Spencer
    Khan, Mehnaz Ali
    Flanagan, Michael
    Washco, Vaughan
    Kasarabada, Aditya
    CHEST, 2021, 160 (04) : 693A - 693A
  • [2] Bevacizumab-induced tracheoesophageal fistula in a patient suffering from lung cancer with bulky subcarinal lymph node: a case report
    Nishie, Kenichi
    Yasuo, Masanori
    Kitaguchi, Yoshiaki
    Kobayashi, Nobumitsu
    Tateishi, Kazunari
    Ushiki, Atsuhito
    Urushihata, Kazuhisa
    Yamamoto, Hiroshi
    Ideura, Gen
    Hanaoka, Masayuki
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2018, 80 (01): : 129 - 134
  • [3] Effectiveness of anlotinib in patients with small-cell lung cancer and pleural effusion: Subgroup analysis from a randomized, multicenter, phase II study
    Liu, Ying
    Cheng, Ying
    Wang, Qiming
    Li, Kai
    Shi, Jianhua
    Wu, Lin
    Han, Baohui
    Chen, Gongyan
    He, Jianxing
    Wang, Jie
    Qin, Haifeng
    Li, Xiaoling
    THORACIC CANCER, 2021, 12 (22) : 3039 - 3045
  • [4] Effect of anlotinib in advanced small cell lung cancer patients with pleural metastases/pleural effusion: A subgroup analysis from a randomized, double-blind phase II trial (ALTER1202)
    Liu, Y.
    Cheng, Y.
    Wang, Q.
    Li, K.
    Shi, J.
    Wu, L.
    Han, B.
    Chen, G.
    He, J.
    Wang, J.
    Qin, H.
    Li, X.
    ANNALS OF ONCOLOGY, 2020, 31 : S1036 - S1036
  • [5] Prospective Study of Chemotherapy in Combination with Cytokine-induced Killer Cells in Patients Suffering from Advanced Non-small Cell Lung Cancer
    Wu, Changping
    Jiang, Jingting
    Shi, Liangrong
    Xu, Ning
    ANTICANCER RESEARCH, 2008, 28 (6B) : 3997 - 4002
  • [6] First report of upfront treatment with Gefitinib in comparison with chemotherapy in advanced nonsmall cell lung cancer patients from south India: Analysis of 120 patients
    Louis, Robert A.
    Rajendranath, Rejiv
    Ganesan, Prasanth
    Sagar, T. G.
    Krishnamurthy, Arvind
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2012, 33 (03) : 146 - 154
  • [7] First Report of Upfront Treatment With Gefitinib in Comparison With Chemotherapy in Advanced Non-Small Cell Lung Cancer Patients From South India - Analysis of 120 Patients
    Louis, R.
    Rajendranath, R.
    Prasanth, G.
    Sagar, T. G.
    Krishnamurthy, A. Arvind
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S628 - S628
  • [8] Time course from first symptom to treatment in patients with non-small cell lung cancer referred for radiotherapy: A report by the CHART Steering Committee
    Dische, S
    Gibson, D
    Parmar, M
    Saunders, MI
    THORAX, 1996, 51 (12) : 1262 - 1265
  • [9] Activation-induced cell death of memory CD8+ T cells from pleural effusion of lung cancer patients is mediated by the type II Fas-induced apoptotic pathway
    Heriberto Prado-Garcia
    Susana Romero-Garcia
    Jorge Morales-Fuentes
    Dolores Aguilar-Cazares
    Jose Sullivan Lopez-Gonzalez
    Cancer Immunology, Immunotherapy, 2012, 61 : 1065 - 1080
  • [10] Activation-induced cell death of memory CD8+ T cells from pleural effusion of lung cancer patients is mediated by the type II Fas-induced apoptotic pathway
    Prado-Garcia, Heriberto
    Romero-Garcia, Susana
    Morales-Fuentes, Jorge
    Aguilar-Cazares, Dolores
    Sullivan Lopez-Gonzalez, Jose
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (07) : 1065 - 1080
12